Innovent Bio
IPOFounded 2011 · $560.0M raised
- Founded
- 2011
- Business Model
- B2B
- Website
- innoventbio.com
- Total Funding
- $560.0M
- Last Round
- $5.0M Series A
- Rounds
- 5
About
Innovent Biologics is a leading biopharmaceutical company founded in 2011 with the mission to provide high-quality biologics that are affordable to all. Through its hallmark integrated approach, state-of-the-art manufacturing facilities, and strategic collaborations, the company is involved in every stage of a drug's lifecycle, from discovery to development to commercialization, building robust pipelines for innovative drugs that treat cancer and other major diseases.
Summary
Innovent Bio is a Biotech company, founded in 2011. It has raised $560.0M in total across 5 rounds. Investors include F-Prime Capital, Eight Roads Ventures and Lilly Asia Ventures.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Oct 2018
Sign up to see all 6 rounds
Series A through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/innovent-bio"><img src="https://indexed.vc/api/badge/company/innovent-bio" alt="Innovent Bio on Indexed.vc" width="260" height="76" /></a>


